UnitedHealthcare said its repaired Medicare Advantage margins let it price 2027 to compete, brokers reported another round of benefit cuts across the industry, and half of the 2027 Star Ratings thresholds got harder to reach.
National headlines
1. UnitedHealthcare signals it will compete on price in Medicare Advantage for 2027
What happened: Speaking at a Wells Fargo healthcare conference on September 9, UnitedHealth CFO Wayne DeVeydt said the company expects to land in the upper half of its 2% to 4% long-term Medicare Advantage margin range this year and that it will be "very competitive" on 2027 pricing and benefits. UnitedHealthcare had just shy of 7.6 million Medicare Advantage members in the second quarter, down from about 8.4 million at the end of 2025, and expects up to 1.1 million fewer members by year end. The CFO said the company still has a few markets where it is right-sizing products. Healthcare Dive also cites a preliminary broker filing, reviewed by Modern Healthcare in August, showing UnitedHealthcare considering exits from 34 counties in 12 states affecting about 20,000 members.
Why it matters: Two years of deliberate shrinkage were about margin, and the company is now telling investors the margin is back. That changes its behavior at AEP: a carrier at the top of its target range has room to fund benefits, stars work and commissions in the markets it kept. The county exits are small, about 1.2% of its Medicare Advantage counties, so the practical effect is concentrated competition rather than further retreat.
Strategic implication: Do not model UnitedHealthcare's 2027 behavior on its 2026 behavior. In the counties it is staying in, assume a more aggressive benefit and distribution posture, and check your AEP forecasts for share you were counting on inheriting from its pullback. Where it is exiting, the 20,000 members are a narrow, identifiable block once plan-level landscape data is public.
Becker's Payer Issues covered the same remarks on September 10. The 34-county figure comes from a preliminary filing reported in August and is included as context, not as a new announcement.
On this site: Carrier footprint · 2027 disruption pipeline
2. Brokers point to another year of broad Medicare Advantage benefit cuts for 2027
What happened: A Leerink analyst note, drawing on insurance broker commentary and reported by Axios on September 10, said 2027 sets up as another year of broad-based industry benefit reductions, with Humana and UnitedHealthcare likely cutting the most. Reported changes include removing Part B giveback benefits, reducing dental coverage, raising specialist copays, increasing out-of-pocket drug costs, and some plans capping enrollment midway through the sign-up period. Axios also cited a HealthScape Advisors survey of leaders at 35 plans earlier this year in which nearly 70% expected less rich overall Medicare Advantage benefit packages in 2027.
Why it matters: When benefit cuts are industry-wide, the comparison shoppers make at AEP shifts from which plan added something to which plan took the least away. Givebacks and dental are the most visible benefits in marketing and broker conversations, so cuts there are felt immediately by members reading their Annual Notice of Change. Mid-period enrollment caps are a newer tool and a signal that some carriers would rather turn away volume than absorb mispriced growth.
Strategic implication: Product and marketing teams should benchmark 2027 designs against competitors' 2027 designs as soon as they are public, not against 2026. A plan that held its giveback or dental benefit while others cut has a message worth leading with; a plan that cut in line with the market needs retention outreach timed to the ANOC mailing. Sales leaders should plan for enrollment caps redirecting volume mid-AEP.
The benefit-cut findings are an analyst's reading of broker commentary, not filed plan data; final 2027 plan details are published by CMS ahead of AEP.
On this site: Carrier & plan intelligence · Marketing intelligence
3. Half of 2027 Medicare Advantage Star Ratings cutpoints got harder to reach
What happened: Draft 2027 Star Ratings cutpoints shared with plans in the week of September 7 show about 50% of thresholds becoming harder to reach, about 33% unchanged and about 17% easier. Examples include the Kidney Health Evaluation for Patients with Diabetes measure, where thresholds rose 7 to 10 points, and Colorectal Cancer Screening, which tightened 4 to 11 points. Three measures, related to pain assessment, medication reconciliation and therapy management reviews, were removed for 2027. Final ratings are expected in early October.
Why it matters: Quality bonus revenue depends on crossing 4 stars, and the bar is moving up on the clinical measures plans can most directly influence. With Medicare Advantage margins already thin, a half-star drop turns directly into lower benchmarks and less money for supplemental benefits in a later plan year.
Strategic implication: Stars teams should rerun contract-level projections against the draft cutpoints now rather than waiting for October, and flag contracts within reach of losing 4 stars to finance and product. Strategy should expect competitors' star positions to shift in early October, which will change the competitive picture in some counties after the 2027 benefit designs are already locked.
Activity date is the reporting date; the article says CMS shared the draft cutpoints with plans earlier the same week.
On this site: Star movement
4. Dual-eligible Medicare Advantage members are switching plans far more often
What happened: A study published in the American Journal of Managed Care on September 9 found that between 2016 and 2022 the share of fully dual-eligible Medicare Advantage members switching plans rose from 12.49% to 22.49%, and partially dual-eligible members from 17.36% to 30.11%. Among non-dual members, switching rose from 9.92% to 13.39%. In 2022, 3.73% of full duals moved from Medicare Advantage back to traditional Medicare, compared with 0.91% of non-duals. The authors noted duals may carry greater disease burden and have more flexibility to switch plans during the year.
Why it matters: Duals are the segment carriers are choosing to grow in, and they are also the most mobile members in Medicare Advantage. Higher-risk enrollees switched more across all groups, which means the members who churn are often the ones whose revenue and care management matter most.
Strategic implication: D-SNP growth plans should carry a retention line, not only an acquisition line. Track month-by-month disenrollment for dual members and treat the first 90 days after enrollment as the retention window. Marketing to duals is a continuous program, and competitors with integrated Medicaid coverage have an advantage in keeping members through eligibility changes.
The study data covers 2016 to 2022; it describes a trend, not a 2026 enrollment figure.
On this site: SNP market · D-SNP marketing
5. Mass General Brigham details the Dana-Farber change: about 1,000 Medicare Advantage members, 90-day transition
What happened: Mass General Brigham Health Plan will remove Dana-Farber Cancer Institute from its Medicare Advantage network effective October 1, 2026, citing the challenging environment affecting Medicare Advantage plans nationwide. About 1,000 Medicare Advantage members who used Dana-Farber in the past year are affected and may continue care there for 90 days. Commercial and MassHealth members keep access. The move follows the planned end of the two institutions' partnership by 2028.
Why it matters: Network narrowing is now being justified openly by Medicare Advantage economics. A named cancer center leaving a network two weeks before AEP is exactly the kind of change that shows up in broker conversations and in the local press during shopping season, regardless of how many members are directly affected.
Strategic implication: In markets where a competitor has lost a marquee provider, the network is a sales argument for the next 90 days. In your own network, identify high-visibility providers whose contracts are at risk before AEP, and have member continuity plans ready. The membership affected is small, but the reputational effect is concentrated in the most engaged, highest-cost members.
First reported by STAT on September 4 and covered in the August 31-September 6 brief. New this week: the affected-member count and the 90-day continuity window. Member count and transition period are from Becker's Payer Issues coverage on September 9.
On this site: Competitor vulnerability
6. Henry Ford's Health Alliance Plan states its strategy: stay in Medicare Advantage while others retreat
What happened: Health Alliance Plan, part of Henry Ford Health in Michigan, reported Medicare Advantage enrollment of 132,566 as of June 30, 2026, up 45.8% from 90,935 a year earlier, adding about 40,000 members while retaining 92% of existing members. It expanded its network across Michigan's entire Lower Peninsula. HAP's president said the plan is "here for the long term," targets a 1% Medicare Advantage margin, and competes on $0 primary care copays and lower out-of-pocket costs. The plan's medical loss ratio was 86.9%.
Why it matters: This is the opposite of the Providence outcome a few weeks earlier: a provider-sponsored plan using national retrenchment to take share rather than being overtaken by it. Its stated margin target of 1% is well below national carriers' 2% to 4% ranges, which lets it hold benefits that others are cutting.
Strategic implication: In markets with an integrated regional plan, the displaced-member opportunity is not uncontested. Expect regional and provider-owned plans to price for growth in 2027. Competitive analysis should weight them by retention and network depth, not just current share.
The enrollment figures were first reported August 26 and covered in the August 24-30 brief. New this week is the plan's stated strategy: Lower Peninsula network expansion, a 1% margin target and the long-term commitment.
On this site: Compare markets · AEP target markets